 Carotid Artery vs Endarterectomy (SPACE) trial was designed to test “equivalence”
between CEA and CAS in patients with neurologic
symptoms but the trial was stopped after recruitment of
1200 patients owing to the futility of proving equivalence
between the two treatments. The 30-day risk of death or
ipsilateral stroke was 6.84% for CAS and 6.34% for CEA in
1183